These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata. Seeman P, Guan HC, Van Tol HH, Niznik HB. Synapse; 1993 Aug; 14(4):247-53. PubMed ID: 8248849 [Abstract] [Full Text] [Related]
8. Link between dopamine D1 and D2 receptors in rat and human striatal tissues. Seeman P, Tallerico T. Synapse; 2003 Mar 15; 47(4):250-4. PubMed ID: 12539197 [Abstract] [Full Text] [Related]
9. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO. Seeman P, Battaglia G, Corti C, Corsi M, Bruno V. Synapse; 2009 Mar 15; 63(3):247-51. PubMed ID: 19084908 [Abstract] [Full Text] [Related]
10. Dopamine receptor pharmacology. Seeman P, Van Tol HH. Curr Opin Neurol Neurosurg; 1993 Aug 15; 6(4):602-8. PubMed ID: 8104554 [Abstract] [Full Text] [Related]
18. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals. Seeman P. Synapse; 2009 Mar 30; 63(3):186-92. PubMed ID: 19086090 [Abstract] [Full Text] [Related]
19. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Ryoo HL, Pierrotti D, Joyce JN. Mov Disord; 1998 Sep 30; 13(5):788-97. PubMed ID: 9756147 [Abstract] [Full Text] [Related]